BNET Industries
Market Cap:$43.9B
Last Fiscal Year Sales:$34.1M
- Public
- UK
Dow Jones Description
Corvus was established to identify assets or companies which are either underperforming against established investment criteria or are undervalued in their current form but can be otherwise acquired or tactically repositioned in order to realise potential value. The Corvus management team has the backing of a number international funding partners. Our considered approach over the last decade has created over $600 million of value for investors across a number of investments, either directly or via special purpose investment vehicles.
CEO
Andrew ReganNumber of Employees 18
Peer Companies
NAICS Code Pharmacies and Drug Stores: 446110
News & Analysis
Filter by
cvs corp. and shoppers drug mart ltd. - All News and Analysis
SDM, CVS take wraps off new concepts in beauty care
NEW YORK -- Late fall 2008 saw the launch of innovative beauty store formats from leading chain drug retailers in both the United States and Canada. In November CVS Caremark Corp. debuted its Beauty 360 prestige beauty store in Washington, D.C., while Shoppers Drug Mart SDM introduced its first...
The top performers set standard for industry
NEW YORK -- Walgreen Co. solidified its position as the chain drug industry's perennial earnings leader by racking up more than $1.5 billion in net income during its last full fiscal year. As the trade class' most profitable company, Walgreens' $1.56 billion in profits was $200 million more than...
Diverse factors coalesce to give drug chains vast growth potential
NEW YORK -- The chain drug industry should continue its winning ways in 2006. Apart from lingering concerns about implementation of the Medicare prescription drug benefit and looming cuts in Medicaid reimbursements, there are few clouds on the horizon that would prevent another year of strong growth in both...
Publicly held drug chains: their five-year track records
Publicly held drug chains: Their five-year track records Corporate sales (add 000) Chain ...
How the top chains measure up
NEW YORK -- Walgreen Co. topped $1 billion in net earnings for the third straight year in 2004, again leading the ranking of the chain drug industry's most profitable companies. Three other chains on the list--CVS Corp., Albertsons Inc. (whose results reflect its supermarket and food/drug combination store operations...
Drugstore.com can't break into the black
BELLEVUE, Wash. -- Despite surging sales, black ink continues to prove elusive for drugstore.com, as the Internet retailer saw losses widen from prior-year levels during the quarter and year ended January 2. In the 14-week fourth quarter of 2004 the company's net loss more than doubled to $5.36 million...
Economy expected to gain momentum
NEW YORK -- Chain drug retailers can expect the economic recovery to continue at a relatively strong pace for the balance of 2004 and into 2005. For members of the trade class that outlook should translate into a strengthening of front-end sales, a line that has slowly been recovering from...
The industry's top performers
NEW YORK -- With more than $1 billion in net earnings for the second consecutive year, Walgreen Co. once again tops the list of the chain drug industry's most profitable companies. Meanwhile, the other four retailers on the list--CVS Corp., Albertsons Inc. (whose results reflect its supermarket and food/drug...
Retailers hype beefed-up beauty sections: full-service departments are turning drug chains into destinations outlets
NEW YORK -- When consumers think about prescriptions, and increasingly about photo and other front-end categories, they think of drug stores first. Chain drug retailers would like to extend that mind-set to beauty care as well. "One of our primary goals is to entice more of our Eckerd customers...
Twenty-five years at a glance
Viewed from the perspectives of 1978 and 2002, the chain drug industry has undergone revolutionary change. But actually the change has been evolutionary--at least until the consolidation of the 1990s--as the following time line reveals. The recapitulation of highlights from 25 years of Chain Drug Review demonstrates that incremental...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Andrew Regan | CEO |
| Julian Moore | Executive Director |
| Joanna Barrett | Executive |
| Michael Hirschfield | Executive |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Adrian Collins | Chairman |
| Edward Hanson | Board of Directors |
| Geoffrey Conway-Henderson | Board of Directors |
| Graham Porter | Board of Directors |
| Ian Tickler | Board of Directors |
| John Leat | Board of Directors |
| Richard Griffiths | Board of Directors |
| Simon Fry | Board of Directors |
Andrew Regan, aged 40, joined the Board as Chief Executive of Corvus Capital Inc in September 2004 and over the following year took the company to record profits of 22.1 million in 2005. Andrew sold his original business to Hobson plc in 1991 where he became Chief Executive of Hobson which was listed on the LSE. In 1994 Hobson plc acquired the Co-operative Wholesale Society's food and drinks manufacturing operations and the enlarged Hobson business was eventually sold to Hillsdown Holdings plc for 154 million by way of a recommended takeover in 1996. In 1997 Andrew led an attempt, which subsequently lapsed, to gain control of the CWS in a 1.2 billion take-over bid. Andrew is based in Geneva and he has no other directorships.
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | CEO | Current |
| Corvus Capital Inc | Chief Executive | Current |
Julian is qualified as a chartered accountant with KPMG in Dublin. He has over seven years? experience in the finance industries in the UK, Ireland and South Africa. Julian is an executive director of Corvus Capital (SA) Holdings Limited, which is listed on the Johannesburg Stock Exchange, and is a consultant to CVS Management Limited and Corvus Capital Inc.
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Executive Director | Current |
| Diamondtech Inc | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Executive | Current |
| Diamondtech Inc | Board of Directors | Current |
| Corvus Capital Inc | Director | Current |
Michael qualified as a chartered accountant with Peat Marwick in 1988. He has held senior management positions with a number of public and private companies and has advised Corvus Capital Inc on its Company Secretary Administration since February 2003 and joined the Board as a non-executive director in January 2007.
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Executive | Current |
| Corvus Capital Inc | Board of Directors | Current |
| Peat Marwick International | Chartered Accountant | Former |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Chairman | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Volume | 20,373,200 |
| Shares Outstanding | 1.4B |
| Market Cap | 43.9B |
| Year High | 38.27 |
| Year Low | 23.74 |
| Earnings Per Share | 2.46 |
| P/E Ratio | 12.6748 |
| Dividend | 0.305 |
| Yield | 0.978191 |
Industry Transcripts by Seeking Alpha
-
Rite Aid Corp. F3Q10 (Qtr End 28/11/09) Earnings Call Transcript
on Dec 17, 2009about RAD
-
Pier 1 Imports, Inc. Q3 2010 Earnings Call Transcript
on Dec 17, 2009about PIR
-
Best Buy F3Q10 (Qtr End 11/28/09) Earnings Call Transcript
on Dec 15, 2009about BBY
-
Costco F1Q10 (Qtr End 11/22/09) Earnings Call Transcript
on Dec 10, 2009about COST
-
The Men’s Wearhouse F3Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about MW
IndustryTop Rated
- Walmart Readies Smaller Stores for Smarter Growth 2 votes
- Walmart Looks to Leave GameStop '4 Dead' This Christmas 2 votes
- Target Challenged on Consumer Perception 1 votes
- Big 5 Sporting Goods Outperforms Peers With Big Discounts 1 votes
- Blackhawk Helping Supermarkets Grab a Chunk of Everyone's Gift Card Business 1 votes



